AVIR Competitors & Alternatives
Compare Atea Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
AVIR
Main Stock$4.98
Tradestie Score
64
Market Cap
$228.55M
Revenue Growth
3.0%
Analyst Upside
+74.0%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALMS
Alumis Inc. Common Stock
|
$26.50
|
$422.50M | - | 60 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$67.60
|
$410.79M | - | 52 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$13.00
|
$407.71M | - | 64 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$15.64
|
$386.68M | - | 58 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.74
|
$382.04M | - | 53 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.23
|
$371.64M | - | 61 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$23.21
|
$357.51M | - | 54 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.63
|
$354.45M | - | 60 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$33.43
|
$353.70M | - | 60 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$2.03
|
$350.98M | - | 57 | Compare |
More AVIR Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry